Transcriptional adaptation is a genetic resistance mechanism in which the decay of defective mRNA in the cytoplasm (outside the cell nucleus) triggers the activation of associated compensatory genes in the nucleus[1]. Scientists have identified the ILF3 protein as a key link linking cytoplasmic mRNA decay to gene activation in the nucleus[1][6]. This process works independently of protein loss – it is not necessary that the missing protein causes the problem, but the decay of the faulty mRNA itself signals the cell to activate backup genes[4]. The cell recognizes which backup genes to activate based on their sequence similarity to the decaying mRNA[6]. This mechanism helps explain why some people with mutations in critical genes survive and function normally, despite the fact that these mutations would be expected to be fatal[1]. The researchers also found that mRNA decay fragments are transported from the cytoplasm to the nucleus, where they trigger increased transcription of adaptation genes[3]. Understanding this process could lead to the development of new therapies that could target this compensatory mechanism[6].